All News

Giredestrant plus Afinitor lowered the risk of cancer worsening or death by 62% in patients with ESR1-mutated, ER-positive, HER2-negative advanced breast cancer.

Five-year results presented at ASTRO 2026 show a five-week radiation schedule after prostatectomy controls cancer as well as a seven-week course. But serious urinary side effects were more common.

A study of more than 17,000 patients ages 23 to 64, presented at ASTRO 2026, found that only about 28% took endocrine therapy consistently for five years, and people who skipped radiation were more likely to fall off. Here's what to weigh before making that choice.

September brought new options for breast, lung, kidney, bile duct, skin and neuroendocrine cancers, plus a brain tumor scan and easier lung cancer treatment.

Dr. Nitin Ohri explains how radiation treats cancer, how often treatment is needed, common side effects and how to tell if radiation is working.

Ivonescimab outperformed Keytruda, a new myeloma drug lowered progression risk by 60% and more: the biggest phase 3 cancer results of September 2026.

Breast cancer treatment has changed dramatically since 2021. Here are the key FDA approvals, year by year, and what they mean for patients.

Choosing hospice care brought comfort, support and precious time for one family as they navigated cancer, caregiving and bringing a loved one home.

Learn how to cope with life after cancer treatment with Dr. Eric Bengtsen, a psycho-oncology psychiatrist at Memorial Sloan Kettering Cancer Center.

On National Previvor Day, learn what it means to carry an inherited gene change like BRCA1 or BRCA2, and the screening and surgery options that lower risk.

Patients with HPV-associated oropharyngeal cancer who received 23% less radiation reported fewer swallowing, voice and dry mouth problems six months after treatment.

Heather Curley discusses her leptomeningeal disease diagnosis, joining an experimental vaccine trial and the milestones she has been able to share with her daughter.

A phase 3 trial presented at ASTRO 2026 found that giving focused radiation in three to five sessions, instead of one, lowered the chance of cancer returning at the surgery site, and patients lived longer.

A new radiation implant placed during surgery for brain metastases nearly stopped tumors from returning and doubled survival, a new study found.

Six years after being diagnosed with B-cell ALL at 21, William Yank opens up about the physical changes of treatment, the emotional weight of constant care and the role hope plays in his survivorship.

Long-term results presented at ASTRO 2026 show that a shorter radiation schedule after mastectomy controls high-risk breast cancer as well as the standard five-week course, without more long-term side effects.

FDA fast-tracks review of elinzanetant for hot flashes linked to breast cancer treatment. Here’s what the trial found and what patients should know.

After two relapses, CAR-T cell therapy, immunotherapy and a stem cell transplant, William Yank's cancer is in remission, where he navigates a new reality shaped by infertility, mental health challenges and a changed sense of self.

A phase 3 trial found proton therapy did not help people with advanced liver cancer live longer than standard photon radiation therapy.

A breast surgeon explains how rebuilding the breast with a person's own tissue and new tools may boost satisfaction and cut repeat surgery.

Some patients with lymphoma show no detectable cancer by day 8 of treatment, and a lymphoma specialist explains how early testing could guide care.

Life after cancer can bring lasting physical, financial and emotional challenges, especially for young survivors navigating life after treatment.

Dr. Maurie Markman discusses how AI could support primary care doctors and specialists caring for patients with cancer while keeping physicians at the center.

A combination of Zenbexus, Darzalex and dexamethasone nearly doubled the rate of deep, MRD-negative responses in relapsed multiple myeloma.

She was diagnosed with stage 4 primary mediastinal B-cell lymphoma (PMBCL), a type of non-Hodgkin lymphoma that starts in the center of the chest, at 29.

Jyoti Malhotra, MD, MPH on first-in-human clinical trials, lung cancer precision medicine in 2026, the disparities tension in drug development, and her move to Yale Cancer Center.

Dr. Maureen McEvoy explains breast cancer surgery options, reconstruction, recovery and how to close gaps in access to care.

For Blood Cancer Awareness Month, Dr. Guenther Koehne shares why immunotherapy is making this a promising time for people with blood cancers.